These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
370 related articles for article (PubMed ID: 19230908)
1. Impact of Clostridium difficile infection on pediatric inflammatory bowel disease. Pascarella F; Martinelli M; Miele E; Del Pezzo M; Roscetto E; Staiano A J Pediatr; 2009 Jun; 154(6):854-8. PubMed ID: 19230908 [TBL] [Abstract][Full Text] [Related]
2. Impact of Clostridium difficile on inflammatory bowel disease. Issa M; Vijayapal A; Graham MB; Beaulieu DB; Otterson MF; Lundeen S; Skaros S; Weber LR; Komorowski RA; Knox JF; Emmons J; Bajaj JS; Binion DG Clin Gastroenterol Hepatol; 2007 Mar; 5(3):345-51. PubMed ID: 17368234 [TBL] [Abstract][Full Text] [Related]
3. Failure of single-toxin assays to detect clostridium difficile infection in pediatric inflammatory bowel disease. Markowitz JE; Brown KA; Mamula P; Drott HR; Piccoli DA; Baldassano RN Am J Gastroenterol; 2001 Sep; 96(9):2688-90. PubMed ID: 11569696 [TBL] [Abstract][Full Text] [Related]
4. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and clostridium difficile infection. Ben-Horin S; Margalit M; Bossuyt P; Maul J; Shapira Y; Bojic D; Chermesh I; Al-Rifai A; Schoepfer A; Bosani M; Allez M; Lakatos PL; Bossa F; Eser A; Stefanelli T; Carbonnel F; Katsanos K; Checchin D; Miera IS; Chowers Y; Moran GW; Clin Gastroenterol Hepatol; 2009 Sep; 7(9):981-7. PubMed ID: 19523534 [TBL] [Abstract][Full Text] [Related]
5. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Nguyen GC; Kaplan GG; Harris ML; Brant SR Am J Gastroenterol; 2008 Jun; 103(6):1443-50. PubMed ID: 18513271 [TBL] [Abstract][Full Text] [Related]
6. Proton pump inhibitors as a risk factor for paediatric Clostridium difficile infection. Turco R; Martinelli M; Miele E; Roscetto E; Del Pezzo M; Greco L; Staiano A Aliment Pharmacol Ther; 2010 Apr; 31(7):754-9. PubMed ID: 20047577 [TBL] [Abstract][Full Text] [Related]
7. Clostridium difficile carriage and serum antitoxin responses in children with inflammatory bowel disease. Hourigan SK; Chirumamilla SR; Ross T; Golub JE; Rabizadeh S; Saeed SA; Elson CO; Kelly CP; Carroll KC; Oliva-Hemker M; Sears C Inflamm Bowel Dis; 2013 Dec; 19(13):2744-52. PubMed ID: 24145927 [TBL] [Abstract][Full Text] [Related]
8. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Clayton EM; Rea MC; Shanahan F; Quigley EM; Kiely B; Hill C; Ross RP Am J Gastroenterol; 2009 May; 104(5):1162-9. PubMed ID: 19319128 [TBL] [Abstract][Full Text] [Related]
9. Polymerase chain reaction test for Clostridium difficile toxin B gene reveals similar prevalence rates in children with and without inflammatory bowel disease. Lamousé-Smith ES; Weber S; Rossi RF; Neinstedt LJ; Mosammaparast N; Sandora TJ; McAdam AJ; Bousvaros A J Pediatr Gastroenterol Nutr; 2013 Sep; 57(3):293-7. PubMed ID: 23698022 [TBL] [Abstract][Full Text] [Related]
10. [The frequency of Clostridium difficile toxin in neutropenic and non-neutropenic patients with antibiotic-associated diarrhea and analysis of the risk factors]. Tunçcan OG; Ulutan F; Karakuş R Mikrobiyol Bul; 2008 Oct; 42(4):573-83. PubMed ID: 19149078 [TBL] [Abstract][Full Text] [Related]
11. Incidence of Clostridium difficile infection in children with inflammatory bowel disease compared to oncology and immunocompetent patients. Hojsak I; Ferenc T; Bojanić K; Mišak Z; Močić Pavić A; Lukić-Grlić A; Kolaček S Digestion; 2012; 86(1):6-11. PubMed ID: 22688504 [TBL] [Abstract][Full Text] [Related]